⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

Official Title: A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer

Study ID: NCT01585987

Study Description

Brief Summary: The purpose of the study is to compare the efficacy of Ipilimumab and standard of care as sequential or maintenance treatment immediately after first-line chemotherapy in the treatment of unresectable or metastatic gastric and gastro-esophageal cancer.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Mount Sinai Medical Center, Miami Beach, Florida, United States

Nyu Clinical Cancer Center, New York, New York, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

The University Of Texas Md Anderson Cancer Center, Houston, Texas, United States

Local Institution, Montpellier Cedex, , France

Local Institution, Nice Cedex 03, , France

Local Institution, Rennes, , France

Local Institution, Toulouse Cedex 09, , France

Local Institution, Mainz, , Germany

Local Institution, Hong Kong, , Hong Kong

Local Institution, Firenze, , Italy

Local Institution, Milano, , Italy

Local Institution, Padova, , Italy

Local Institution, Pisa, , Italy

Local Institution, Roma, , Italy

Local Institution, Nagoya, Aichi, Japan

Local Institution, Saku-shi, Nagano, Japan

Local Institution, Osaka-sayama-shi, Osaka, Japan

Local Institution, Kitaadachi-gun, Saitama, Japan

Local Institution, Gyeonggi-do, , Korea, Republic of

Local Institution, Gyeonggi-do, , Korea, Republic of

Local Institution, Seoul, , Korea, Republic of

Local Institution, Seoul, , Korea, Republic of

Local Institution, Seoul, , Korea, Republic of

Local Institution, Katowice, Ochojec, Poland

Local Institution, Krakow, , Poland

Local Institution, Lodz, , Poland

Local Institution, Olsztyn, , Poland

Local Institution, Moscow, , Russian Federation

Local Institution, Singapore, , Singapore

Local Institution, Singapore, , Singapore

Local Institution, Barcelona, , Spain

Local Institution, Madrid, , Spain

Local Institution, Madrid, , Spain

Local Institution, Taipei, , Taiwan

Local Institution, Taipei, , Taiwan

Contact Details

Name: Bristol-Myers Squibb

Affiliation: Bristol-Myers Squibb

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: